Oncogenic mutations in KRAS are critical drivers of colorectal cancer, studies have reported that the upregulation of GLUT1 expression and increased glucose uptake primarily depend on KRAS and BRAF mutations in CRC cells. This evidence concerns the gene SLC2A1 and colorectal carcinoma.